Consultations and regulation · 24 March 2026
Why Australian clinics cannot advertise prescription injectables
Schedule 4 medicines are not shop-window products. This explainer sets out TGA advertising limits in plain English, why names and nicknames are avoided, and how to read a clinic website that stays vague without treating vagueness as a sales technique.

RAOeser. Light shinning through a window.jpg. CC BY-SA 4.0. Wikimedia Commons. Source · CC BY-SA 4.0 All image credits
If you have hunted for a product name on an Australian clinic website and found only fog, the fog may be the point. Many injectable medicines used in aesthetic practice are prescription-only. The law that governs therapeutic goods is not a style guide. It is a rule about what may be promoted to the public, and it is older than Instagram.
This is a public-interest explainer, not a catalogue. It will not name products, nicknames, or hashtags. It will not tell you what to buy. It will tell you why a careful clinic sounds strangely unspecific, and how to tell that unspecificity from a sales trick that has borrowed the same quiet.
Schedule 4, in ordinary language
Australia classifies medicines into schedules. The schedules describe how a substance may be supplied. Schedule 4 is the everyday home of prescription-only medicines: they are not ordinary retail. An authorised prescriber has to be involved. A pharmacist, in the usual pattern, dispenses. The details vary with the medicine and the setting, but the idea is stable. The public does not self-select these medicines from a poster.
That classification is why advertising is different from, say, advertising a moisturiser. The Therapeutic Goods Administration administers rules that tightly limit advertising of prescription-only medicines to the public. The concern is not etiquette. It is that advertising short-circuits the decision that is supposed to happen between a person and a prescriber, with a history taken and alternatives considered.
Cosmetic use does not lift a medicine out of its schedule. A substance does not become a beauty product because it is discussed in a well-lit room. If it is Schedule 4, it remains a prescription-only medicine when the indication is appearance. Clinics that understand this will not treat a vial as a featured item.
State and territory health departments also publish consumer material on cosmetic injections. The TGA has a checklist aimed at people considering those procedures. Read those pages for current, official wording. This essay will not try to replace them with a clever summary.
Why product names and nicknames are avoided
A trade name is an advertisement if it is used to promote supply to the public. So, often, is a nickname that everyone in a comments section understands as the same medicine. Hashtags, misspellings, and wink-wink abbreviations are not a clever loophole. They are just louder pointing.
This is why you will see category language, or no language at all, on sites that are trying to stay inside the rules. It can feel unhelpful when you wanted a comparison table. Comparison tables are what retailers make. Prescribers are asked to do something else: decide whether a medicine is appropriate for a particular person, at a particular time, with particular risks.
You should not try to complete that decision in a search bar. If you already have a name in mind from overseas media, park it. Bring the concern instead: a line, a volume change, a function, a dislike. A consultation that begins with a product is already facing the wrong direction.
Nicknames also travel with testimonials and with before-and-after culture, which Australian advertising rules separately restrict for regulated health services. The combination — a coded product plus a stranger’s face plus a star rating — is the opposite of a prescription. If you see that combination, you are not looking at compliance. You are looking at a feed that has decided the rules are for other people. Our essay on online red flags is about that pattern.
Offering a consultation is not the same as advertising a medicine
There is a lawful, ordinary thing a clinic can do: say that registered practitioners are available to consult about appearance concerns, to take a history, and to discuss options, including doing nothing. That is an offer of a health service. It is not, by itself, an advertisement for a Schedule 4 medicine.
The difference is easy to feel when it is done well. The page names people you can check on the Ahpra register. It talks about assessment, consent, and follow-up. It does not dangle a substance. It does not price a substance. It does not tell you that a substance is right for you before anyone has met you.
The difference is also easy to fake. “Book a consultation” can be a thin wrapper around a product funnel: a quiz that spits out a package, a receptionist who asks which medicine you want, a price list that appears as soon as you sit down, a reminder that the special ends tonight. In that version the consultation is a corridor, not a decision. You are entitled to walk back out of the corridor.
Prescription requires a prescriber who is actually entitled to prescribe. Nurses, nurse practitioners and medical practitioners have different scopes. Remote prescribing, photograph-based prescribing, and “the doctor will sign off later” arrangements should be explained in concrete terms: who, when, how identity is confirmed, how you ask questions of the prescriber, how after-hours contact works. If the only person you meet cannot prescribe, you should know that before you undress.
How to read a website that stays vague
Vague can be honest. Vague can be lazy. Vague can be strategic. You distinguish them by what is specific instead of the product.
Specific and careful: named practitioners with registrable surnames; a statement that some treatments involve prescription-only medicines that cannot be advertised; an invitation to a consultation; a warning that not everyone is a candidate; a note that you will receive written information and time. That page is trying not to sell you a medicine. It may still be trying to sell you an appointment. You can live with that if the appointment itself is allowed to conclude in a no.
Specific and loud: unnamed team; category words paired with heart-eye photographs; reviews used as proof; timers; financing in the first screen; a blog that is only a list of coded product posts. That page is using the legal constraint as mood lighting. It stays vague where the TGA is watching and concrete where conversion happens.
Pay attention to the blog and the captions, not only the homepage. Advertising law is not limited to a single banner. A clinic that is austere in its official copy and florid on social media is still speaking to the public. Read the florid channel. That is where nicknames, testimonials, and implied results tend to live.
When you arrive in person, keep the same distinction. It is reasonable that a practitioner will not confirm a product choice in a public waiting room, and reasonable that written materials about a medicine appear after an assessment, not in a window. It is not reasonable that you never hear material risks, never hear alternatives, and never get information you can take home. The ban on advertising a medicine is not a ban on explaining a medicine to the person who might use it.
What this means for you as a reader
You do not need to become an amateur scheduler of medicines. You need a smaller civic skill: stop treating missing product names as either incompetence or intrigue. Often it is compliance. Then apply a second skill: do not let compliance in one column excuse sloppiness in the others.
Ask who prescribes. Ask who performs. Ask how follow-up works if you live a long drive from the rooms. Ask what happens if you change your mind. Ask for written estimates that do not pretend a prescription-only medicine is a shop special. Those questions belong in the consultation, not in a search bar.
If you want official consumer guidance, use it. The TGA’s material on cosmetic injections, Ahpra’s register, and the Ahpra cosmetic surgery hub for surgical questions are the primary documents. State health pages are written for the public on purpose. They are drier than a feed, and that dryness is a feature.
A clinic that cannot advertise a vial still has to deserve your time. The law keeps the vial out of the window. It does not put wisdom in the room. That part is still a conversation, with a registered person, which you can postpone or refuse. The quiet on the website is only useful if the noise stops there.
Questions readers usually ask
- Why don’t Australian clinic websites name anti-wrinkle products?
- Many injectable products used in aesthetic practice are prescription-only medicines. Advertising those medicines to the public is restricted under therapeutic goods law. A website that avoids trade names and nicknames may be attempting to comply. You should still expect a named, registered prescriber and a proper consultation.
- Is it legal for a clinic to talk about cosmetic injections at all?
- Clinics can describe that they offer practitioner-led consultations about appearance concerns. That is different from advertising a particular medicine, a bargain, or a promised change. The line is about promoting a therapeutic good to the public without the safeguards of a prescription. When in doubt, read the TGA’s consumer material on cosmetic injections and ask the clinic to explain their wording.
- What is a Schedule 4 medicine in this context?
- In the scheduling system used in Australia, Schedule 4 covers prescription-only medicines. They are supplied on the authority of an authorised prescriber, not selected off a menu. The schedule is a legal classification, not a marketing category. If a substance sits in that schedule, public advertising is tightly limited.
- How should I interpret a clinic page that only says ‘consultation’?
- It may be lawful caution. It may also be a way of staying interesting while saying little. Judge the page by whether it names registered practitioners, explains consent, and avoids testimonials and timers. A vague product description plus a hard sell on booking is not caution. It is a funnel.